Bajpai A

References (3)

Title : Indanone: a promising scaffold for new drug discovery against neurodegenerative disorders - Bansal_2024_Drug.Discov.Today__104063
Author(s) : Bansal R , Singh R , Shubra Dutta T , Ahmad Dar Z , Bajpai A
Ref : Drug Discov Today , :104063 , 2024
Abstract :
PubMedSearch : Bansal_2024_Drug.Discov.Today__104063
PubMedID: 38901670

Title : AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model - Bradley_2010_Neuropharmacol_58_365
Author(s) : Bradley SR , Lameh J , Ohrmund L , Son T , Bajpai A , Nguyen D , Friberg M , Burstein ES , Spalding TA , Ott TR , Schiffer HH , Tabatabaei A , McFarland K , Davis RE , Bonhaus DW
Ref : Neuropharmacology , 58 :365 , 2010
Abstract :
PubMedSearch : Bradley_2010_Neuropharmacol_58_365
PubMedID: 19835892

Title : Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine: evidence for three distinct modes of receptor activation - Spalding_2006_Mol.Pharmacol_70_1974
Author(s) : Spalding TA , Ma JN , Ott TR , Friberg M , Bajpai A , Bradley SR , Davis RE , Brann MR , Burstein ES
Ref : Molecular Pharmacology , 70 :1974 , 2006
Abstract :
PubMedSearch : Spalding_2006_Mol.Pharmacol_70_1974
PubMedID: 16959945